The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Red blood cells: the forgotten player in hemostasis and thrombosis
Open accessAbstract
New evidence has stirred up a long‐standing but undeservedly forgotten interest in the role of erythrocytes, or red blood cells (RBCs), in blood clotting and its disorders. This review summarizes the most recent research that describes the involvement of RBCs in hemostasis and thrombosis. There are both quantitative and qualitative changes in RBCs that affect bleeding and thrombosis, as well as interactions of RBCs with cellular and molecular components of the hemostatic system. The changes in RBCs that affect hemostasis and thrombosis include RBC counts or hematocrit (modulating blood rheology through viscosity) and qualitative changes, such as deformability, aggregation, expression of adhesive proteins and phosphatidylserine, release of extracellular microvesicles, and hemolysis. The pathogenic mechanisms implicated in thrombotic and hemorrhagic risk include variable adherence of RBCs to the vessel wall, which depends on the functional state of RBCs and/or endothelium, modulation of platelet reactivity and platelet margination, alterations of fibrin structure and reduced susceptibility to fibrinolysis, modulation of nitric oxide availability, and the levels of von Willebrand factor and factor VIII in blood related to the ABO blood group system. RBCs are involved in platelet‐driven contraction of clots and thrombi that results in formation of a tightly packed array of polyhedral erythrocytes, or polyhedrocytes, which comprises a nearly impermeable barrier that is important for hemostasis and wound healing. The revisited notion of the importance of RBCs is largely based on clinical and experimental associations between RBCs and thrombosis or bleeding, implying that RBCs are a prospective therapeutic target in hemostatic and thrombotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Duration of Red-Cell Storage and Complications after Cardiac Surgery
Koch, C. G., Li, L., Sessler, D. I., Figueroa, P., Hoeltge, G. A., Mihaljevic, T., & Blackstone, E. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070403 · Cited by 1,363
Cellular Mechanisms Underlying the Formation of Circulating Microparticles
Morel, O., Jesel, L., Freyssinet, J.-M., & Toti, F. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.200956 · Cited by 526
DUKE, W. W. (1910) · Journal of the American Medical Association · doi:10.1001/jama.1910.04330140029009 · Cited by 478
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., & Freyssinet, J.-M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000246775.14471.26 · Cited by 460
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins, P. V., & O’Donnell, J. S. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00975.x · Cited by 431
Cines, D. B., Lebedeva, T., Nagaswami, C., Hayes, V., Massefski, W., Litvinov, R. I., Rauova, L., Lowery, T. J., & Weisel, J. W. (2014) · Blood · doi:10.1182/blood-2013-08-523860 · Cited by 420
Self-citationComposition of Coronary Thrombus in Acute Myocardial Infarction
Silvain, J., Collet, J.-P., Nagaswami, C., Beygui, F., Edmondson, K. E., Bellemain-Appaix, A., Cayla, G., Pena, A., Brugier, D., Barthelemy, O., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.077 · Cited by 393
Self-citationSqueezing for Life – Properties of Red Blood Cell Deformability
Huisjes, R., Bogdanova, A., van Solinge, W. W., Schiffelers, R. M., Kaestner, L., & van Wijk, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00656 · Cited by 321
Barabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Cited by
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
The Hemocompatibility of Nanoparticles: A Review of Cell–Nanoparticle Interactions and Hemostasis
de la Harpe, K., Kondiah, P., Choonara, Y., Marimuthu, T., du Toit, L., & Pillay, V. (2019) · Cells · doi:10.3390/cells8101209 · Cited by 368
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Ramlall, V., Thangaraj, P. M., Meydan, C., Foox, J., Butler, D., Kim, J., May, B., De Freitas, J. K., Glicksberg, B. S., Mason, C. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1021-2 · Cited by 351
Design of biopolymer-based hemostatic material: Starting from molecular structures and forms
Zou, C.-Y., Li, Q.-J., Hu, J.-J., Song, Y.-T., Zhang, Q.-Y., Nie, R., Li-Ling, J., & Xie, H.-Q. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100468 · Cited by 87
Metadata
- Authors
- Weisel, J. W., & Litvinov, R. I.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 17
- Issue
- 2
- Pages
- 271-282
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W2910814638
- Cited by
- 492
- References
- 75
- FWCI
- 31.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Red blood cells: the forgotten player in hemostasis and thrombosis. https://app.cochat.ai/papers/10.1111/jth.14360
- The paper
- Weisel, J. W., & Litvinov, R. I. (2019). Red blood cells: the forgotten player in hemostasis and thrombosis. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.14360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.